Qingfang Miao

Statistics

Publications

Citations

345

H-Index

Active since

2007

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Affiliated Hospital of Qingdao University

Beijing Friendship Hospital

Qingdao University

Capital Medical University

Qingfang Miao is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in oncology, molecular oncology, and medicine.

Publications per year

2007–2022

Publications

Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models

Cuicui Li, Jun Liu, Xu Yang et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2022 · 45 citations

Medicine, Oncology, Pharmacology +16

An <scp>EGFR</scp>‐targeting antibody–drug conjugate <scp>LR</scp>004‐<scp>VC</scp>‐<scp>MMAE</scp>: potential in esophageal squamous cell carcinoma and other malignancies

Xinyue Hu, Rong Wang, Jie Jin et al. · Molecular Oncology · 2018 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17

A tandem scFv-based fusion protein and its enediyne-energized analogue show intensified therapeutic efficacy against lung carcinoma xenograft in athymic mice

Genshen Zhong, Shenghua Zhang, Yi Li et al. · Cancer Letters · 2010 · 34 citations

Medicine, Medicinal Chemistry, Oncology +10

A novel enediyne‐integrated antibody–drug conjugate shows promising antitumor efficacy against CD30<sup>+</sup> lymphomas

Rong Wang, Liang Li, Shenghua Zhang et al. · Molecular Oncology · 2018 · 30 citations · Full text

Medicine, Medicinal Chemistry, Oncology +13

A recombinantly tailored β-defensin that displays intensive macropinocytosis-mediated uptake exerting potent efficacy against K-Ras mutant pancreatic cancer

Yue Du, Bo-Yang Shang, Weijin Sheng et al. · Oncotarget · 2016 · 28 citations · Full text

Medicine, Oncology, Pharmacology +13

1–5 of 17